Literature DB >> 22818067

Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation.

Marylyn D Ritchie1, Shane Rowan, Gayle Kucera, Tanya Stubblefield, Marcia Blair, Shannon Carter, Dan M Roden, Dawood Darbar.   

Abstract

OBJECTIVES: The aim of this study was to test the hypothesis that 2 common polymorphisms in the chromosome 4q25 region that have been associated with atrial fibrillation (AF) contribute to the variable penetrance of familial AF.
BACKGROUND: Although mutations in ion channels, gap junction proteins, and signaling molecules have been described for Mendelian forms of AF, penetrance is highly variable. Recent studies have consistently identified 2 common single-nucleotide polymorphisms in the chromosome 4q25 region as independent AF susceptibility alleles.
METHODS: Eleven families in which AF was present in ≥2 members who also shared a candidate gene mutation were studied. These mutations were identified in all subjects with familial lone AF (n = 33) as well as apparently unaffected family members (age >50 years with no AF; n = 17).
RESULTS: Mutations were identified in SCN5A (n = 6), NPPA (n = 2), KCNQ1 (n = 1), KCNA5 (n = 1), and NKX2.5 (n = 1). In genetic association analyses, unstratified and stratified according to age of onset of AF and unaffected age >50 years, there was a highly statistically significant association between the presence of both common (rs2200733 and rs10033464) and rare variants and AF (unstratified p = 1 × 10(-8), stratified [age of onset <50 years and unaffected age >50 years] p = 7.6 × 10(-5)) (unstratified p < 0.0001, stratified [age of onset <50 years and unaffected age >50 years] p < 0.0001). Genetic association analyses showed that the presence of common 4q25 risk alleles predicted whether carriers of rare mutations developed AF (p = 2.2 × 10(-4)).
CONCLUSIONS: Common AF-associated 4q25 polymorphisms modify the clinical expression of latent cardiac ion channel and signaling molecule gene mutations associated with familial AF. These findings support the idea that the genetic architecture of AF is complex and includes both rare and common genetic variants.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818067      PMCID: PMC3448817          DOI: 10.1016/j.jacc.2012.04.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

1.  Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation.

Authors:  P T Ellinor; R K Moore; K K Patton; J N Ruskin; M R Pollak; C A Macrae
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study.

Authors:  Arne Pfeufer; Shapour Jalilzadeh; Siegfried Perz; Jakob C Mueller; Martin Hinterseer; Thomas Illig; Mahmut Akyol; Cornelia Huth; Andreas Schöpfer-Wendels; Bernhard Kuch; Gerhard Steinbeck; Rolf Holle; Michael Näbauer; H-Erich Wichmann; Thomas Meitinger; Stefan Kääb
Journal:  Circ Res       Date:  2005-03-03       Impact factor: 17.367

3.  Familial aggregation in lone atrial fibrillation.

Authors:  Patrick T Ellinor; Danita M Yoerger; Jeremy N Ruskin; Calum A MacRae
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.

Authors:  Daniel F Gudbjartsson; Hilma Holm; Solveig Gretarsdottir; Gudmar Thorleifsson; G Bragi Walters; Gudmundur Thorgeirsson; Jeffrey Gulcher; Ellisiv B Mathiesen; Inger Njølstad; Audhild Nyrnes; Tom Wilsgaard; Erin M Hald; Kristian Hveem; Camilla Stoltenberg; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Maggie C Y Ng; Larry Baum; Wing Yee So; Ka Sing Wong; Juliana C N Chan; Christian Gieger; H-Erich Wichmann; Andreas Gschwendtner; Martin Dichgans; Gregor Kuhlenbäumer; Klaus Berger; E Bernd Ringelstein; Steve Bevan; Hugh S Markus; Konstantinos Kostulas; Jan Hillert; Sigurlaug Sveinbjörnsdóttir; Einar M Valdimarsson; Maja-Lisa Løchen; Ronald C W Ma; Dawood Darbar; Augustine Kong; David O Arnar; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

5.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

6.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

7.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Authors:  Caroline S Fox; Helen Parise; Ralph B D'Agostino; Donald M Lloyd-Jones; Ramachandran S Vasan; Thomas J Wang; Daniel Levy; Philip A Wolf; Emelia J Benjamin
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

8.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; D D Savage; R J Garrison; K M Anderson; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

9.  Familial atrial fibrillation is a genetically heterogeneous disorder.

Authors:  Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Arshad Jahangir; Bernard J Gersh; Win-K Shen; Stephen C Hammill; Douglas L Packer; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

View more
  34 in total

1.  Repolarization recipes for atrial fibrillation: beyond single channel variants.

Authors:  Dawood Darbar; Babar Parvez; Robert Abraham
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

2.  PITX2: a master regulator of cardiac channelopathy in atrial fibrillation?

Authors:  Na Li; Dobromir Dobrev; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2016-01-17       Impact factor: 10.787

3.  Candidate gene approach to identifying rare genetic variants associated with lone atrial fibrillation.

Authors:  Peter Weeke; Babar Parvez; Marcia Blair; Laura Short; Christie Ingram; Gayle Kucera; Tanya Stubblefield; Dan M Roden; Dawood Darbar
Journal:  Heart Rhythm       Date:  2013-10-10       Impact factor: 6.343

Review 4.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 5.  Highlights of the year in JACC 2012.

Authors:  Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-01-22       Impact factor: 24.094

Review 6.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

Review 7.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

8.  Association of atrial fibrillation with gene polymorphisms of connexin 40 and angiotensin II receptor type 1 in Chongming adults of Shanghai.

Authors:  Shuxin Hou; Yingmin Lu; Damin Huang; Xiaohan Luo; Dongmei Yue; Jinchun Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 9.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

Review 10.  Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future?

Authors:  William J Hucker; Harsimran Saini; Steven A Lubitz; Patrick T Ellinor
Journal:  Can J Cardiol       Date:  2016-02-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.